{
    "Trade/Device Name(s)": [
        "Enzymatic Creatinine Assay",
        "Enzymatic Creatinine Assay (265 series)"
    ],
    "Submitter Information": "Diagnostic Chemicals Limited",
    "510(k) Number": "K070383",
    "Predicate Device Reference 510(k) Number(s)": [
        "K003261"
    ],
    "Regulatory Class": "Class II",
    "Product Code(s)": [
        "JFY"
    ],
    "Summary Letter Date": "June 22, 2007",
    "Summary Letter Received Date": "May 04, 2007",
    "Submission Date": "April 11, 2007",
    "Regulation Number(s)": [
        "21CFR862.1225"
    ],
    "Regulation Name(s)": [
        "Creatinine Test System"
    ],
    "Analyte Class(es)": [
        "chemistry"
    ],
    "Analyte(s)": [
        "Creatinine"
    ],
    "Specimen Type(s)": [
        "Serum",
        "Plasma",
        "Urine"
    ],
    "Specimen Container(s)": [],
    "Instrument(s)/Platform(s)": [
        "Roche automated clinical chemistry analyzers"
    ],
    "Method(s)/Technology(ies)": [
        "Enzymatic assay"
    ],
    "Methodologies": [
        "Quantitative determination"
    ],
    "Submission Type(s)": [
        "Reagent"
    ],
    "Document Summary": "FDA 510(k) summary for Diagnostic Chemicals Limited Enzymatic Creatinine Assay for quantitative measurement of creatinine in serum, plasma, and urine using enzymatic methodology",
    "Indications for Use Summary": "For the quantitative determination of creatinine in serum, plasma and urine; used in diagnosis and treatment of renal diseases, monitoring renal dialysis, and as a calculation basis for measuring other urine analytes for professional in vitro diagnostic use only",
    "fda_folder": "Clinical Chemistry"
}